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Abstract 
Chlorothalonil is an important broad spectrum fungicide widely used in agriculture, silviculture, 
and urban settings. As a result of its massive use, chlorothalonil was found in all environmental 
matrices, with consequent risks to the health of terrestrial and aquatic organisms, as well as for 
humans.  
We analysed the effects of chlorothalonil on human lymphocytes using in vitro chromosomal 
aberrations and micronuclei assays. Lymphocyte were exposed to five concentrations of 
chlorothalonil: 0.600 µg/mL, 0.060 µg/mL, 0.030 µg/mL, 0.020 µg/mL, and 0.015 µg/mL, where 
0.020 and 0.600 µg/mL represent the ADI and the ARfD concentration values, respectively, 
established by FAO/WHO for this compound; 0.030 and 0.060 µg/mL represent intermediate values 
of these concentrations and 0.015 µg/mL represents the ADI value established by the Canadian 
health and welfare agency.  
We observed cytogenetic effects of chlorothalonil on cultured human lymphocytes in terms of 
increased CAs and MNs frequencies at all tested concentrations, including the FAO/WHO ADI and 
ARfD values of 0.020 and 0.600 µg/mL, respectively, but with exception of the Canadian ADI 
value of 0.015 µg/mL.  
Finally, no sexes differences were found in the levels of chromosomal aberrations and micronuclei 
induced by different Chlorothalonil concentrations, as well as a significant reduction of the CBPI 
was not observed, indicating that Chlorothalonil does not seem to produce effects on the 
proliferation/mitotic index when its concentration is equal or less than 0.020 µg/mL.  
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1. Introduction 
Chlorothalonil (CHT), is a broad spectrum, non-systemic chlorinated isophtalonitrile fungicide 
widely used in agriculture, silviculture, and urban settings. It reacts with functional cellular thiols 
and inhibits fungal respiration and energy metabolism. For this reason, it was used to control fungal 
and bacterial infestations in many fruit, vegetable and agricultural crops including peanuts, 
tomatoes, potatoes, onions and celery (FAO/WHO, 2010). 
As a result of its massive use, CHT was found in all environmental matrices and its possible 
genotoxicity has been investigated by many authors. CHT was found to be relatively non-toxic for 
avian species, small mammals and honeybees, but highly toxic for fish, crustaceans, birds, 
amphibians and aquatic invertebrates (Gallo and Tosti, 2015; McMahon et al., 2011; Yu et al., 
2013; Shelley et al., 2009; Guerreiro et al., 2017; Du Gas et al., 2017). Moreover, in rodents, 
chronic dietary exposure to CHT was found to cause an increased incidence of papillomas and 
carcinomas of the stomach squamous epithelium as well as of adenomas and carcinomas of the 
renal proximal tubule epithelium (Van Scoy and Tjeerdema, 2014; FAO/WHO, 1992).  
In humans, CHT exposure was associated with contact dermatitis, severe eye and skin irritation and 
gastrointestinal problems. In particular, allergic contact dermatitis, conjunctivitis and upper airway 
complaints were described in fruit and vegetable growers (Penagos, 2002; Penagos et al., 2004), in 
floriculturists and in trailer tent factory workers (Lensen et al., 2007; 2011). Vice versa, 
epidemiological evidences for an association between CHT and different type of cancers, such as 
colon, lung, and prostate cancers among humans were not found (Mozzachio et al., 2008).  
Form genotoxic point of view, in vivo results showed that, mice and Chinese hamsters chronically 
treated with CHT revealed increased levels of DNA damage in terms of chromosomal aberrations 
(CAs) and sister chromatid exchanges (SCEs) (Dearfield et al., 1993). Moreover, Lebailly et coll. 
(1998), using the alkaline comet assay, observed increased levels of DNA damage in mononuclear 
leukocytes of farmers exposed to selected pesticides, including CHT.  
	 	
On the other hand, in vitro studies showed that CHT failed to induce CAs and micronuclei (MNs) in 
mammalian cell lines (Vigreux et al., 1998), whereas positive results in terms of loss of cell 
viability and increased frequencies of damaged cells were found in human peripheral blood 
lymphocytes analyzed with the SCGE assay (Lebailly et al., 1997).  
Based on evidences of carcinogenicity from animal studies but no from human epidemiologic data, 
CHT was classified by U.S. Environmental Protection Agency (EPA) as a Group B2 (probable 
human carcinogen) (EPA, 1999). Similarly, the International Agency for Research on Cancers 
(IARC), despite the lack of available data about human carcinogenicity, classified CHT as a 
possible carcinogen (2B) (IARC, 1999). Different FAO/WHO reviews confirmed that CHT did not 
show a genotoxic hazard for humans and, on the basis of the available information, estimated the 
Acceptable Daily Intake (ADI) value to 0-0.02 mg/kg/ bw and the Acceptable Reference Dose 
value to 0.6 mg/kg/ bw (FAO/WHO, 2010). However, it should be emphasized that, in a previous 
published report and partially in contrast to FAO/WHO, the Canadian health and welfare agency 
established for CHT the more stringent ADI concentration value of 0-0.015 mg/kg/ bw (HWC, 
1994).  
The widespread use of CHT in agriculture and the limited data about its genotoxicity in humans 
lymphocytes, prompted us to investigate the frequency of CAs and MNs in human peripheral 
lymphocytes after in vitro exposure to different concentrations of this pesticide, including those of 
0.020 and 0.600 µg/mL that represent the ADI and Acceptable Reference Dose (ARfD), 
respectively, established by FAO/WHO for this compound, and the concentration of 0.015 µg/mL, 
that represents the ADI-value established by the Canadian health and welfare agency.  
Among cytogenetic test systems, CAs and MNs assays are important tools in the measurement of 
the genotoxic potential of many chemicals. The CAs assay allows the detection of cells carrying 
unstable aberrations (i.e. chromosome/chromatid breaks, fragments, rings and dicentrics) that will 
lead to cell death during proliferation (Garcia-Sagredo, 2008). On the other hand, MNs assay allows 
	 	
evaluation of both potential clastogenic and/or aneugenic effects of different xenobiotics. In 
particular, MNs originates from acentric chromosome fragments or whole chromosomes that fail to 
segregate properly during mitotic division and appear in the cytoplasm of interphase cells as small 
additional nuclei (Fenech, 2016). Interestingly, previous published studies provided evidences for a 
relationship between high levels of CAs and MNs in peripheral blood lymphocytes and increase of 
cancer risk (Bonassi et al., 2004, 2011).  
 
2. Materials and Methods 
 
2.1. Chemicals and reagents 
 
The IUPAC name of CHT is: Tetrachloroisophthalonitrile (CAS n. 1897-45-6). The CHT (obtained 
from Labservices, Bologna, Italy) was first dissolved in DMSO (CAS no. 67-68-5) at a final 
concentration of 0.6 mg/mL (stock solution) and was kept at 4°C until prepared for the final 
exposure solutions in culture medium. Gibco RPMI 1640 cell culture media supplemented with L-
glutamine, foetal calf serum, phytohemagglutinin (PHA), and antibiotics were purchased from 
Invitrogen-Life Technologies, Milan, Italy. Cytochalasin-B and Mitomycin-C (MMC) were 
obtained from Sigma-Aldrich, Milan, Italy. Methanol, Acetic acid, Giemsa stain solution, and 
conventional microscope slides were purchased from Carlo Erba Reagenti, Milan, Italy. Potassium 
chloride (KCl) and  Sörensen buffer were obtained from Merck S.p.A., Milan, Italy. Vacutainer 
blood collection tubes were from Terumo Europe, Rome, Italy. Distilled water was used throughout 
the experiments.  
 
2.2. Subjects 
 
	 	
Peripheral venous blood was collected from 6 healthy subjects (3 males and 3 females, mean 
age±S.E., 32.90±1.84, range 23-40 years), non-smoking, not alcoholics, not under drug therapy, and 
with no recent history of exposure to mutagens. Informed consent was obtained from all blood 
donors. The study was approved by the local ethics committee and was performed in accordance 
with the ethical standards laid down in the 1964 Declaration of Helsinki.  
 
2.3. Blood Sample Collection and Lymphocyte cultures 
 
Blood samples were obtained by venipuncture, collected in heparinised tubes, cooled (4°C) and 
processed within 2 h after collection. Heparinised venous blood (0.3 mL) were cultured in 25 cm2 
flasks containing 6 mL of RPMI-1640 medium, 2 mL of foetal calf serum (FCS), 200 µL of the 
mitogenic agent Phytohemagglutinin-L, and 100 µL of antibiotics solution (100 IU/mL penicillin, 
and 100 µg/mL streptomycin), for a total of 8.6 mL for each lymphocyte culture. The cultures were 
successively incubated at 37°C, under 5% of CO2 in the air in a humidified atmosphere. After 24 h 
of incubation, 8.6 µL of CHT stock solution at concentration of 0.6 mg/mL were added to the 
lymphocyte culture in order to reach a final CHT concentration of 0.600 µg/mL. Similarly, 8.6 µL 
of CHT stock solution diluted 10, 20, 30 and 40 times with DMSO were added to the lymphocyte 
cultures in order to reach the final CHT concentrations of 0.060 µg/mL, 0.030 µg/mL, 0.020 µg/mL 
and 0.015 µg/mL, respectively. In particular, 0.020 and 0.600 µg/mL represent the ADI and the 
ARfD concentrations, respectively, established by FAO/WHO for this compound, 0.030 and 0.060 
µg/mL intermediate values of these concentrations and 0.015 µg/mL represent the ADI 
concentration established by Canadian health and welfare agency. Three control cultures were 
assessed: 1) positive control, by adding only MMC (final concentration 0.1 µg/mL culture); 2) 0.1% 
DMSO solvent control, obtained by adding 8.6 µL of DMSO to the lymphocyte culture; 3) negative 
control culture without both CHT and DMSO, obtained adding 8.6 µL of RPMI medium to the 
	 	
lymphocyte culture. Only for MNs assay, after 44 h of incubation, cytochalasin-B was added to the 
cultures at a concentration of 6 µg/mL to block cytokinesis.  
Fixation of lymphocyte cultures was performed with a fresh mixture of methanol/acetic acid (3:1 
v/v), using the procedure described in our previous published article (Santovito et al., 2018).  
 
2.4. Cytokinesis-Block Micronucleus and Chromosomal Aberration Assays  
 
Micronucleus and chromosomal aberration assays were performed according to previously 
described procedures (Santovito et al., 2018). MNs and CAs were scored in 1,000 binucleated 
lymphocytes and 200 well-spread complete metaphases per donor per concentration, respectively. 
The cytokinesis-block proliferation index (CBPI) was calculated, according to the following 
formula: [1 × N1] + [2 × N2] + [3 × (N3 + N4)]/N, where N1–N4 represents the number of cells 
with 1-4 nuclei, respectively, and N is the total number of cells scored. 
 
2.5. Statistical analysis 
 
Comparison of mean values of the percentage of cells with MNs, CBPI and CAs between exposure 
levels and their controls was assessed by the non-parametric Mann-Whitney test. Statistical 
calculations were carried out using the SPSS software package program (version 23.0, Inc., 
Chicago, IL, USA). All P values were two tailed, and P values of 5% or less were considered 
statistically significant for all tests carried out. 
 
3. Results 
 
3.1. Effect of CHT on CAs formation 
	 	
Table 1 shows values of CAs found in the human peripheral lymphocytes cultured in the presence 
of different CHT concentrations.  
 
Insert Table 1 
 
CHT was found to induce seven types of structural CAs (gaps, chromatid and chromosome breaks, 
dicentric chromosomes, rings, acentric fragments and rearrangements). The most frequent observed 
aberrations were acentric fragments and chromatid aberrations, respectively, whereas no numerical 
aberrations were found.  
Because of the conflicting opinions about the possibility to consider gaps as indicators of genomic 
damage (Savage JR, 2004), we decided to exclude gaps from statistical analysis. 
Data obtained indicated that human lymphocytes treated in vitro with CHT significantly (P = 0.004) 
increased the CAs and Aberrant Cells (Ab.C) frequencies at all tested concentrations when 
compared with the solvent control, including the concentration of 0.020 µg/mL (P = 0.009) that 
represents the ADI value established by FAO/WHO for this substance, but with exception of 0.015 
µg/mL. Moreover, a dose-effect was observed since the regression analysis revealed a significant 
(P<0.001) correlation between the CHT concentrations and the level of genomic damage (Table 2). 
 
Insert Table 2 
 
Vice versa, no significant differences were found between the DMSO solvent-control and the 
negative control, whereas the cultures treated with the known mutagen MMC showed a significant 
increase of CAs and Ab.C with respect to all CHT tested concentrations, including the negative and 
solvent control cultures. Finally, no sexes differences were found in the levels of CAs induced by 
different CHT concentrations, with exception of MMC although with a borderline P-value of 0.046 
(Table 3). 
	 	
 
Insert Table 3 
 
3.2. Effect of CHT on MNs formation 
 
To verify both the aneugenic and clastogenic effects of CHT, the MNs test was assessed in parallel 
with CAs test (Table 4).  
 
Insert Table 4 
 
Similarly to what we already observed with the CAs assay, our results indicated that CHT 
significantly increased (P = 0.004) the MNs formation at all tested concentrations (including di 
established ADI value of 0.020 µg/mL), with exception of 0.015 µg/mL. Moreover, a dose-effect 
was observed since the regression analysis revealed a significant (P<0.001) correlation between the 
CHT concentrations and the frequencies of MNs and Cells with MNs (Table 2).  
Also in this case, the DMSO solvent-control cultures did not show any difference with the negative 
controls (P = 0.126), further confirming that at this low concentration DMSO has no cytogenetic 
effects evaluable by MN test. MMC showed a significant increase in the MNs formation compared 
with the negative control (P = 0.019), solvent controls (P = 0.020) and all tested concentrations of 
CHT (P = 0.029 and for 0.06 µg/mL and P = 0.021 for both 0.030 and 0.020 µg/mL) with exception 
of 0.600 µg/mL (P = 0.139). After 48-h exposure, a significant reduction of the CBPI value in 
cultures treated with CHT was not observed, indicating that at the tested concentrations, CHT does 
not seem to produce effects on the proliferation/mitotic index. 
Similarly to what observed by CAs assay, females shows higher frequencies of MNs at all CHT 
concentrations tested, although these differences were not significant. The only exception was 
	 	
observed at the CHT concentration of 0.600 µg/ml, although, also in this case, with a borderline P-
value of 0.046 (Table 5). 
 
Insert Table 5 
 
4. Discussion 
 
Exposure to pesticides is known to be an important environmental risk factor associated with the 
development of cancer (Miligi et al., 2006; Alavanja et al., 2005). However, insufficient data are 
present in literature about the genotoxicity of many commercially available pesticides. In particular, 
the genotoxic potential of CHT was evaluated in different in vitro and in vivo studies but observed 
data were, in some cases, contradictory (Vigreux et al., 1998; Lebailly et al., 1997). 
Results obtained in the present study evidenced a possible clastogenic and/or aneugenic effect of 
the CHT on human lymphocytes, also at the concentration of 0.020 µg/mL that represents the ADI 
value established for humans by FAO/WHO (2010). Our data seem to be concordant with results 
obtained by other authors with different cell lines and/or different assays. Lebailly et coll. (1997), 
by a SCGE assay, observed a significant effects of CHT on human peripheral blood lymphocytes in 
terms of cell viability and DNA-damage. Similarly, CHT was found to induce SCEs and CAs in 
vitro in Chinese hamster ovary cells (Dearfield et al., 1993), whereas in vivo this increase of the 
DNA damage was observed in rat, mouse and Chinese hamster only after a chronic treatment for 5 
successive days, but not after a single dose treatment (Dearfield et al., 1993). However, it should be 
emphasized that all data about CHT genotoxicity should be interpreted with particular attention also 
in view of the fact that, in pesticide formulations used by farmers, CHT is frequently associated to 
other pesticides, such as carbendazim, that are known to enhance the genotoxic effect of CHT on 
human PBL (Lebailly et al., 1997).  
The mechanisms underlying genotoxic potential of CHT alone or in complexation with other 
	 	
compounds are unknown, although it was known that exposure to CHT may trigger cytotoxic and 
inflammatory processes. These last  were found able to induce DNA damage and the loss of cellular 
membrane integrity (Wilkinson and Killeen, 1996) as well as cytogenetic damage  (Higashimoto et 
al., 2006; Santovito et al., 2016). In this sense, it is our opinion that the increase of cytogenetic 
damage observed by our group with both CAs and MNs assays, and by other groups with different 
assays and cell lines, requires further investigations and should pushes towards the adoption of 
lower reference limits. Indeed, increased CAs and MNs frequencies in peripheral blood 
lymphocytes have been positively associated with increased cancer risk and early events in 
carcinogenesis, respectively (Bonassi et al., 2004; 2011). Moreover, CHT was found to have in 
vitro tumor promoting effects in Syrian hamster embryo cells (Bessi et al., 1999), whereas, in vivo, 
chronic dietary treatment with CHT was found to causes in rodents (rats and mice) increased 
incidence of papillomas and carcinomas of the forestomach squamous epithelium and adenomas 
and carcinomas of the renal proximal tubule epithelium (Wilkinson and Killeen, 1996). All these 
considerations and the fact that also in our study we do not observed clastogenic/aneugenic effects 
at the CHT concentration of 0.015 µg/mL, seem to justify the Canadian health and welfare agency 
that, in contrast to FAO/WHO, established for CHT a lower ADI-value of 0-0.015 mg/kg/day 
(HWC 1994).  
As the role of sex, in the present study females showed higher levels of genomic damage than 
males, although with non-statistically significant values. The only exceptions were represented by 
MMC in the CAs assay and the 0.6 µg/mL of CHT for the MNs, although both with a borderline P-
value of 0.046 (Table 5). However, it should be emphasized that the small sample size, typical of an 
in vitro study, does not allow to drawn definitive conclusions. In our previous in vivo studies 
involving a larger number of subjects, the results related to a possible role of sex in determining the 
level of genomic damage were conflicting. Indeed, a positive association between the frequencies of 
CAs, sister chromatid exchanges and sex was found by our group in two control populations (n = 
	 	
101 and n = 230, respectively), with females showing higher levels of genomic damage (Santovito 
et al., 2017), whereas in another study this association was not observed (Santovito et al., 2016) 
Finally, the CBPI value was decreased with CHT treatments. However, this reduction was not 
statistically significant, indicating that CHT does not seem to produce significant effects on the 
proliferation/mitotic index when its concentration is equal or less than 0.020 µg/mL.  
 
5. Conclusion 
 
The results herein reported showed cytogenetic effects of CHT on cultured human lymphocytes in 
terms of increased CAs and MNs frequencies. Although simple experimental models like 
mammalian and bacterial cells cannot accurately mimic the complex in vivo kinetics of xenobiotic 
compounds, results we obtained with CHT point to the necessity of further investigations in order to 
establish the real genotoxic potential of this compound, alone and/or in association with other 
compounds, and, eventually, the adoption of more stringent measures able to reduce the presence of 
this compound in the environment and to minimize the adverse effects of the CHT exposure on 
human health.  
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Table 1 – Induction of chromosomal aberrations by Chlorothalonil in human lymphocytes in vitro.  
Number of scored metaphases for each concentration of the test substance = 1200 
CAs = chromosomal aberrations; Ab.C = aberrant cells (cells with 1 ore more aberrations);  
B’: chromatid break; B’’: chromosome break; DC: dicentric; R: ring; TR = tri-tetraradials; AF = acentric fragments; Re = 
rearrangements; S.E. = standard error; NC = Negative Control; MMC = Mitomycin-C; CHT = chlorothalonil;  
aP = 0.004, bP = 0.009 (significantly differs from DMSO solvent control) 
 	
 
  
Test substance 
(µg/ml) 
CAs 
 
Gaps    B’    B’’   DC   R   TR   AF  Re 
CAs CAs +  Gaps Ab.C 
Ab.C + 
Gaps 
 
(%) CAs/Cell  
± S.E. 
 
 
(%) Ab.C/Cell ± 
S.E. 
 
NC  3 10 0 0 0 0 2 3 15 18 15 18 1.250±0.214 1.250±0.214 
0.1% DMSO 5 13 2 1 0 0 3 2 20 25 20 25 1.6700±0.211 1.6700±0.211 
MMC (0.100) 29 35 21 7 9 3 40 13 128 157 124 153 10.667±1.388 a 10.333±1.160 a 
CHT (0.600) 5 23 7 6 6 0 27 10 79 84 78 83 6.583±0.352 a 6.500±0.288 a 
CHT (0.060) 3 20 7 3 1 0 18 10 59 62 59 62 4.917±0.417 a 4.917±0.417 a 
CHT (0.030) 5 18 8 0 1 0 18 12 57 62 57 62 4.750±0.382 a 4.750±0.382 a 
CHT (0.020) 4 10 1 3 1 0 19 2 36 40 36 40 3.000±0. 423 b 3.000±0. 423 b 
CHT (0.015) 5 10 1 0 0 0 13 1 25 30 25 30 2.083±0.327 2.083±0.327 
	 	
Table 2 - Regression analysis evaluating the relationship between the different 
 Chlorothalonil concentrations and the level of genomic damage 
 
Biomarkers β-co P-value 95% CI (Lower) – (Upper) 
CAs 
Cells with CAs 
MNs 
Cells with MNs 
CBPI 
0.870 
0.873 
0.863 
0.879 
0.199 
<0.001 
<0.001 
<0.001 
<0.001 
0.292 
(1.705) – (2.661)  
(1.686) - (2.614)  
(3.221) – (5.113) 
(2.949) – (4.517) 
(-0.042) – (0.013) 
CAs = Chromosomal Aberrations; MNs = micronuclei;  
CBPI = Cytokinesis-Block Proliferation Index; β-co = β-coefficient;  
CI = Confidence Interval 
 	 	
	 	
Table 3  – Induction of chromosomal aberrations by Chlorothalonil in human lymphocytes in vitro,  
                            according to sex. Number of scored metaphases for each concentration of Chlorothalonil = 1200 
 
 
 
 
 
 
 
 
 
 
 
 
 
CAs = chromosomal aberrations; Ab.C = aberrant cells (cells with 1 ore more aberrations);  
S.E. = standard error; NC = Negative Control; MMC = Mitomycin-C; CHT = chlorothalonil;  
*P = 0.046  
  
Test substance 
(µg/ml)    
FEMALES 
   CAs/Cell ± S.E.          Ab.C/Cell±S.E. 
  (%)                                 (%) 
MALES 
   CAs/Cell ± S.E.          Ab.C/Cell±S.E. 
  (%)                                 (%) 
NC  1.500±0.289 1.500±0.289 1.000±0.289 1.000±0.289 
0.1% DMSO 1.833±0.333 1.833±0.333 1.500±0.289 1.500±0.289 
MMC (0.100) 12.833±2.088* 12.166±1.667 8.500±0.763* 8.500±0.763 
CHT (0.600) 7.167±0.441 7.167±0.441 6.000±0.289 6.000±0.289 
CHT (0.060) 5.500±0.577 5.500±0.577 4.333±0.441 4.333±0.441 
CHT (0.030) 5.167±0.333 5.167±0.333 4.333±0.667 4.333±0.667 
CHT (0.020) 3.333±0.601 3.333±0.601 2.667±0.333 2.667±0.333 
CHT (0.015) 2.333±0.333 2.333±0.333 1.8333±0.601 1.8333±0.601 
	 	
Table 4 - Induction of micronuclei produced by Chlorothalonil in human lymphocytes in vitro.  
Number of scored binucleated cells for each concentration of the test substance = 6000 
 
Test substance 
(µg/ml) 
Distribution of BNCs 
according to the 
number of MNs 
1     2     3      4     
MNs 
 
Ab.C 
 
MN/cell  
± S.E. (%) 
Ab.C/cell  
± S.E. (%) CBPI ± S.E 
NC 10 1 0 0 12 11 0.200±0.052 0.183±0.048 1.665±0.047 
0.1% DMSO 23 0 0 0 23 23 0.383±0.087 0.425±0.025 1.593±0.059 
MMC (0.100) 157 9 2 1 185 169 3.083±0.403 a 2.817±0.340 a 1.348±0.015 d 
CHT (0.600) 101 5 0 2 119 108 1.983±0.271 a 1.817±0.227 a 1.523±0.041 
CHT (0.060) 91 4 0 1 103 96 1.750±0.173 a 1.600±0.113 a 1.524±0.028 
CHT (0.030) 65 3 1 0 74 69 1.233±0.099 a 1.150±0.089 a 1.536±0.011 
CHT (0.020) 39 1 0 0 41 40 0.683±0.060 b 0.667±0.059 c 1.563±0.063 
CHT (0.015) 25 0 0 0 25 25 0.417±0.048 0.417±0.048 1.575±0.058 
BNCs = Binucleated cells; MNs = micronuclei; Ab.C = cells with 1 or more micronuclei;  
CBPI = Cytokinesis-Block Proliferation Index = [1 × N1] + [2 × N2] + [3 × (N3 + N4)]/N, where N1–N4 represents the 
number of cells with 1-4 nuclei, respectively, and N is the total number of cells scored; S.E. = Standard Error; NC = 
Negative Control; CHT = Chlorothalonil; MMC = Mitomycin-C.  
aP = 0.004, bP = 0.024, cP = 0.005, dP = 0.020 (significantly differs from DMSO solvent control) 	
 
  
	 	
Table 5 - Induction of micronuclei produced by Chlorothalonil in human lymphocytes in vitro, according to sex.  
Number of scored binucleated cells for each concentration of Chlorothalonil = 6000 
 
 FEMALES MALES      
Test substance 
(µg/ml) 
MN/cell±S.E. 
(%) 
Ab.C/cell±S.E. 
(%) 
CBPI±S.E. MN/cell±S.E. 
(%) 
Ab.C/cell±S.E. 
(%) 
CBPI±S.E. 
NC 0.267±0.033 0.267±0.033 1.637±0.064 0.067±0.088 0.050±0.058 1.693±0.051 
0.1% DMSO 0.233±0.088 0.233±0.088 1.653±0.040 0.267±0.088 0.267±0.088 1.532±0.109 
MMC (0.100) 2.533±0.318 2.367±0.260 1.365±0.023 1.817±0.639 1.633±0.555 1.330±0.017 
CHT (0.600) 1.400±0.153* 1.300±0.115 1.590±0.030 1.283±0.067* 1.150±0.058 1.457±0.054 
CHT (0.060) 1.800±0.321 1.600±0.231 1.542±0.043 0.817±0.120 0.800±0.100 1.505±0.042 
CHT (0.030) 1.100±0.153 1.000±0.116 1.521±0.019 0.683±0.088 0.650±0.058 1.551±0.077 
CHT (0.020) 0.633±0.088 0.600±0.058 1.620±0.014 0.367±0.088 0.367±0.088 1.507±0.128 
CHT (0.015) 0.333±0.033 0.333±0.033 1.626±0.009 0.250±0.058 0.250±0.058 1.524±0.119 
BNCs = Binucleated cells; MNs = micronuclei; Ab.C = cells with 1 or more micronuclei;  
CBPI = Cytokinesis-Block Proliferation Index = [1 × N1] + [2 × N2] + [3 × (N3 + N4)]/N, where N1–N4 represents the 
number of cells with 1-4 nuclei, respectively, and N is the total number of cells scored; S.E. = Standard Error; NC = 
Negative Control; CHT = Chlorothalonil; MMC = Mitomycin-C.  
*P = 0.046. 
 	
